Scilex Holding (SCLXW)
0.17
-0.03 (-14.57%)
At close: Feb 10, 2025, 3:57 PM
0.17
0.00%
After-hours Feb 10, 2025, 05:00 PM EST
undefined% (undefined)
| Bid | 0.08 |
| Market Cap | 76.25M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.32 |
| Volume | 20,282 |
| Avg. Volume (20D) | 12,689.546 |
| Open | 0.15 |
| Previous Close | 0.20 |
| Day's Range | 0.15 - 0.17 |
| 52-Week Range | 0.15 - 0.17 |
| Beta | undefined |
About SCLXW
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company's principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid f...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date n/a
Employees 113
Stock Exchange NASDAQ
Ticker Symbol SCLXW
Website https://www.scilexholding.com